NCT03964519 is a NA clinical trial of Acute changes in Healthy, sponsored by Alejandro Muñoz López.

Who is sponsoring NCT03964519?

NCT03964519 is sponsored by Alejandro Muñoz López.

What drugs are being tested in NCT03964519?

Interventions in NCT03964519: Acute changes, Chronic changes, Familiarization.

Is NCT03964519 still recruiting?

NCT03964519 is currently status unknown. Last updated 29 May 2019.

Last reviewed 2019-05-29 · How we verify

NCT03964519

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of an Acute and Chronic Training Protocol Associated to the Inter-set Velocity Loss

Status unknown NA Last updated 29 May 2019

What this trial tests

NA trial testing Acute changes in Healthy in 30 participants. Status unknown.

Timeline

1 July 2019

Primary endpoint
30 August 2019

15 September 2019

Quick facts

Lead sponsor	Alejandro Muñoz López
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	single
Primary purpose	other
Enrollment	30
Start date	1 July 2019
Primary completion	30 August 2019
Estimated completion	15 September 2019

Drugs / interventions tested

Acute changes
Chronic changes
Familiarization

Conditions studied

Healthy — all drugs for Healthy →

Sponsor

Alejandro Muñoz López

Who can join

Adults 18 to 30, male only, with Healthy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluates different performance, physiological and neuromuscular changes after acute and chronic resistance training intervention in physically active men. The participants will train with a single exercise (full squat) and will be monitored with a linear encoder. The experiment will consist of between 3 to 6 sets between 70% to 85% of 1RM in the full squat exercise. Two main groups will form the intervention: one group will perform inter-set repetitions until there will be a 20% of velocity loss compared to the first repetition, while the second group will have a 40% of velocity loss.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Healthy

Currently open trials in the same condition.

NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03964519 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Alejandro Muñoz López
Last refreshed: 29 May 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03964519.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing